Imperial College London

ProfessorEricAlton

Faculty of MedicineNational Heart & Lung Institute

Chair in Gene Therapy
 
 
 
//

Contact

 

+44 (0)20 7594 7937e.alton

 
 
//

Location

 

Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Summary

Eric Alton is Professor of Gene Therapy and Respiratory Medicine, National Heart & Lung Institute, Imperial College London and Honorary Consultant Physician, Royal Brompton Hospital

Professor Alton was educated at Jesus College, Cambridge and Westminster Medical School and subsequently undertook six years of general medical training.  Over the last fifteen years, he has been involved in developing gene therapy for cystic fibrosis and angiogenesis, including three clinical trials.

Professor Alton coordinates the UK CF Gene Therapy Consortium which brings together the three centres in the UK (Edinburgh and Oxford Universities and Imperial College), including approximately 80 clinicians and scientists focused on this problem.

 

Publications

Journals

Griesenbach U, Paul-Smith M, Pytel K, et al., The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins, Gene Therapy, ISSN:0969-7128

Thursfield RM, Naderi K, Leaver N, et al., 2018, Children with cystic fibrosis demonstrate no respiratory immunological, infective or physiological, consequences of vitamin D deficiency., J Cyst Fibros

Turnbull AR, Murphy R, Behrends V, et al., 2018, Impact of T2R38 Receptor Polymorphisms on Pseudomonas aeruginosa Infection in Cystic Fibrosis., Am J Respir Crit Care Med

Conference

Shovlin CL, Nur F, St Prix MS, et al., 2018, Hereditary haemorrhagic telangiectasia and the 100,000 genomes project, SPRINGER, Pages:125-125, ISSN:0969-6970

Coates M, Ito K, Alton E, et al., 2017, RSV INFECTION LEADS TO INCREASED BINDING OF PSEUDOMONAS AERUGINOSA TO PHE508DEL CFTR EXPRESSING RESPIRATORY EPITHELIAL CELLS, WILEY, Pages:S375-S375, ISSN:8755-6863

More Publications